Study Stopped
PI wanted to discontinue study.
Affective Processing in Depression and Epilepsy
2 other identifiers
observational
14
1 country
1
Brief Summary
The goal of this study is to determine whether there are unique markers on neuroimaging that are associated with depression in epilepsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 3, 2009
CompletedFirst Posted
Study publicly available on registry
March 4, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedJuly 9, 2009
July 1, 2009
1 year
March 3, 2009
July 8, 2009
Conditions
Keywords
Interventions
Subjects will undergo MRI scanning to gather data about cognetive functions.
Investigator will evalute the subject during a one on one interview for depression using the Hamilton Depression Rating Scale.
Subjects will complete self assessment to evaluate their level of depression.
Subject will complete self assessment to determine if there have been any changes in mood, emotions and or feelings from time to time.
Eligibility Criteria
There are four study groups. 1. Healthy Controls 2. Subjects with epilepsy only 3. Subjects with primary depression only 4. Subjects with epilepsy and depressive symptoms.
You may qualify if:
- Healthy adults of 18 years of age or older.
You may not qualify if:
- Subject has no history of affective disorders
- Subject scores higher than 5 on Hamilton Depression Rating Scale
- Subject with prior primary diagnosis of any psychotic disorder, bipolar disorder, anxiety disorder, or any other serious medical or neurological disorder
- Subject is pregnant
- Subject is unable to undergo a MRI
- Epilepsy Only Group
- Subject is at least 18 years of age
- Subject has confirmed temporal lobe epilepsy (TLE)
- Subject has a history of depression
- Subject scores higher then 5 on Hamilton Depression Rating Scale
- Subject with prior primary diagnosis of any psychotic disorder, bipolar disorder, anxiety disorder, or any other serious medical or neurological disorder
- Subject is pregnant
- Subject is unable to undergo a MRI
- Depression Only Group
- Subject is at least 18 years of age
- +15 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwell Healthlead
Study Sites (1)
North Shore LIJ Health System
Manhasset, New York, 11030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alan Ettinger, M.D.
Northwell Health
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 3, 2009
First Posted
March 4, 2009
Study Start
June 1, 2008
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
July 9, 2009
Record last verified: 2009-07